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     BSTRACT
In this case report, a markedly painful ulcerative dermatitis consistent with pyoderma 
granulosum is reported in a 2.5-year-old entire female Maltese dog. The dog had a nasal stridor 
and irregular ulcers with raised inflammatory borders involving the lumbar area, tail and the 
hindlimbs. The lesions did not respond to antibiotics. Histopathologic features include deep 
crateriform ulcerations with massive infiltrations of neutrophils beneath and adjacent to the 
ulcers. Treatment with prednisolone (Kela Laboratories, Sint-Niklaas, Belgium) alone resulted 
in the resolution of nasal signs and all skin lesions.
SAMENVATTING
In deze casuïstiek wordt een opvallend pijnlijke, ulceratieve dermatitis overeenstemmend met 
pyoderma gangrenosum beschreven bij een 2,5 jaar oude, intacte, vrouwelijke maltezer. De hond had 
een nasale stridor en vertoonde onregelmatige ulceraties met verheven inflammatoire randen op de 
lenden, staart en achterste ledematen. Er was geen respons op diverse antibiotica. Het histopathologisch 
beeld werd gekenmerkt door diepe kratervormige ulceraties met een uitgesproken neutrofiel infiltraat, 
onderliggend en aan de randen van de verzweringen. Een behandeling met enkel prednisolone (Kela 
Laboratories, Sint-Niklaas, Belgium) resulteerde in een complete regressie van de nasale symptomen 
en huidletsels.
A
  Case report 
INTRODUCTION
Pyoderma gangrenosum (PG) is a rare, destructive, 
reactive sterile inflammatory skin disease (Gross et 
al., 2005; Miller et al., 2013). Only three cases have 
been reported in dogs in the peer-reviewed literature 
(Bardagi et al., 2007; Simpson et al., 2013). It is one of 
the group of neutrophilic dermatoses in dogs that also 
includes subcorneal pustular dermatosis and Sweet’s 
syndrome. Canine PG lesions are described as multifo-
cal, markedly painful, hemorraghic pustules and nod-
ules, which breakdown to form discharging irregular 
ulcers with elevated undermined borders. Lesions typi-
cally involve the trunk, particularly the dorsum, but 
also the face, the limbs, the tail base and tail. Mucosal 
involvement has not been reported. The phenomenon 
of pathergy or Koebner phenomenon (new lesions 
forming in response to minor trauma) and the clinical 
finding of cribriform scarring, minor human diagnostic 
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criteria, have been documented in two dogs (Simpson 
et al., 2013). Dogs may be febrile and depressed. In 
humans, PG may either be idiopathic or associated 
with underlying systemic disease, or more rarely, has 
been linked to many kinds of surgery and various drugs 
(Ruocco et al., 2009). Canine PG has been associated 
with preceding polyarthritis in one dog (Bardagi et al., 
2007), and considered idiopathic in two dogs (Simpson 
et al., 2013). PG is diagnosed by compatible clinical 
features, with exclusion of other (infectious) causes of 
ulcerative disease, and by supportive histopathology 
(characteristic large crateriform ulcers with massive 
infiltrations of neutrophils beneath and adjacent to the 
ulcers) (Gross et al., 2005; Ruocco et al., 2009). The de-
termination of whether there is a an associated disorder 
is mandatory (Ruocco et al., 2009). Reported effective 
treatments in the dog include oral prednisolone in con-
junction with ciclosporin (Bardagi et al., 2007) or with 
azathioprine (Simpson et al., 2013).
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In the present report, the clinical aspects of PG in 
a Maltese dog and the successful treatment with pred-
nisolone alone are described. 
CASE DESCRIPTION
A 2.5-year-old, entire female Maltese dog was pre-
sented with a five-week history of a painful and pro-
gressive skin eruption that started on the dorsal trunk 
and a five-day history of nasal stridor and sneezing. 
Treatment prior to presentation included an unknown 
course of oral cephalexin, followed by an unknown 
course of oral doxycycline (Ronaxan, Merial Belgium, 
Diegem) combined with oral meloxicam (Meloxoral, 
Le Vet B.V., Oudewater, the Netherlands). No further 
therapeutic information was available. Five days prior 
to admission, the dog had received orally 3 mg/kg ve-
rafloxacin (Veraflox, Bayer Austria GmbH, Vienna, 
Austria) given once a day. The previous medical his-
tory revealed two antecedents of back pain, respec-
tively two months and one month before the onset of 
the skin condition, which had been treated each time 
with five-day courses of meloxicam orally 0.1 mg/kg 
once daily. On several occasions, the dog had travel-
led with the owners to Spain.
Upon physical examination, the skin lesions were 
so painful that the dog had to be muzzled. When 
muzzled, ‘bubble blowing’ (nasal formation of air 
bubbles) was observed (Figure 1). Rectal temperature 
was 39.2°C. The peripheral lymph nodes were normal 
on palpation. There were only few skin lesions pres-
ent. A cluster of lesions -some of them had coalesced- 
involved the dorsal lumbar region. Solitary and more 
extensive lesions were present on the dorsal proximal 
part of the tail and on the lateral aspects of both tarsi. 
The skin lesions were irregular ulcers covered by 
crusts. The ulcers had an elevated purulent border and 
a necrotic base (Figure 2), or had a margin surround-
ed by a halo of bright erythema. An extensive crusted 
lesion on the tail was discharging hemorraghic 
exudate and its proximal margin revealed hemorraghic 
pustulation (Figure 3). Differential diagnoses included 
deep bacterial pyoderma, fungal infection, leish-
maniosis, vasculitis and pyoderma gangrenosum.
A complete blood count, serum biochemistry 
profile and cytology of ulcerated skin were per-
formed. Multiple skin biopsies were submitted for 
histopathology. Cytology revealed purulent inflam-
mation but no micro-organisms. A complete blood 
count showed mild neutrophilia 16.9 x 109/L (nor-
mal range 6.0 – 12.0 x 109/L). No abnormalities 
were found on serum biochemistry. Leishmania in-
fantum antibodies titres were not detected. While 
awaiting the histopathological findings, verafloxacin 
therapy was continued. The skin lesions had not im-
proved at day 15. No micro-organisms were identi-
fied on histopathology on hematoxylin and eosin, 
and periodic acid Schiff stains. Histopathological 
Figure 1. Photograph of the muzzled ‘bubble blowing’ 
dog.
Figure 2. Photograph of the flank. Small irregular ulcer 
with a raised inflammatory border and a necrotic base.
Figure 3. Photograph of the tail. Extensive crusted le-
sion discharging a hemorraghic exudate. Inset shows 
hemorraghic pustulation (arrow) arising at its proximal 
border.
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examination revealed large crateriform ulcers, that 
penetrate to the deep dermis and often extend into 
the  panniculus, with massive infiltrations of neutro-
phils beneath and adjacent to the ulcers (Figure 4). 
Superficial dermal neutrophilic inflammation was sur-
rounded by mononuclear cells (Figures 5 and 6).
Pyoderma gangrenosum was diagnosed and an-
tibiotics were stopped. Treatment with 1 mg/kg oral 
prednisolone (Prednisolone, Kela Laboratories, Sint-
Niklaas, Belgium) twice a day was initiated. One week 
later, the owner reported a marked improvement. The 
cutaneous pain and nasal stridor had resolved. Treat-
ment was continued. On re-examination, after five 
weeks of twice-daily prednisolone 1 mg/kg, the skin 
lesions were completely resolved, except for the alo-
pecia and scarring. The prednisolone dosage was then 
reduced to 1.2 mg/kg given once every second day for 
three weeks, and finally given once every third day 
for another three weeks. The dog was followed up for 
eight months and no relapse occurred.
 
DISCUSSION
The diagnosis of PG rests primarily upon clinical 
features and exclusion of other causes of ulceration, 
as there is no specific laboratory test and as the histo-
pathology is indicative, but not diagnostic (Gross et 
al., 2005; Ruocco et al., 2009). In both humans and 
dogs, one of the hallmark signs of PG is evidence of 
extreme pain disproportionate to the gross appearance 
of the lesions. The salient clinical feature is an ulcer 
Figure 4. Photomicrograph. Large dermal pustule and 
crateriform ulceration extending into the panniculus. 
Note marked neutrophilic infiltrate. Hematoxylin and 
eosin stain 40x.
Figure 5. Photomicrograph. Subepidermal neutrophilic 
infiltrate surrounded by mononuclear cells adjacent to 
an ulceration. Hematoxylin and eosin stain 200x.
with a raised inflammatory and irregular border and 
a necrotic base (Ruocco et al., 2009; Simpson et al., 
2013).
The dog in the present report had skin lesions con-
sistent with PG. The lesions were markedly painful, 
irregular ulcers with an elevated inflammatory border 
and a necrotic base or ulcers with the margins sur-
rounded by a halo of bright erythema. The extensive 
lesion on the dorsal tail was discharging a hemorrhagic 
exudate and had a hemorraghic pustulation arising on 
its proximal border. Moreover, there was no lymph-
adenopathy, an invariably feature in humans (Ruocco 
et al., 2009). A Koebner phenomenon, present in 20% 
of human cases, and cribriform scarring were lack-
ing diagnostic criteria. In published dog cases, these 
Figure 6. Photomicrograph. Closer view of the same 
section as in figure 5. Hematoxylin and eosin stain 400x.
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criteria have not always been present (Bardagi et al., 
2007). The lesion distribution in de present case was 
trunk, tail and limbs, which fits with the description in 
published canine PG cases. 
The involvement of mucous membranes has not 
been reported in canine PG, but has occasionally been 
observed in human PG (Ruocco et al., 2009). The dog 
in the present case had a late history of nasal disease 
characterized by nasal stridor, sneezing and ‘bubble 
blowing’. Its nasal signs readily responded to predniso- 
lone treatment. Therefore, it was reasonable to sus-
pect nasal mucosa involvement in the dog’s condition. 
However, true evidence by microscopic demonstration 
of neutrophilic mucosal inflammation, was lacking. 
Infectious causes of cutaneous ulceration were ruled 
out by the lack of micro-organisms on cytology and 
histopathology and by the lack of response to anti-
biotics of different classes, e. i. cephalexin, doxy-
cycline, verafloxacin. Histopathological findings of 
large crateriform ulcers were non-specific, but were 
highly supportive for PG in conjunction with clinical 
features and the lack of response to antibiotics (Gross 
et al., 2005; Ruocco et al., 2009).
Underlying conditions could not be identified. In-
terestingly, prior to the onset of the skin lesions, the 
dog of this report had been treated twice with meloxi-
cam for back pain. Triggering of PG by these ante-
cedents or by the administered meloxicam cannot be 
completely discarded.
There is no specific and uniformly effective therapy 
for PG. Systemic corticosteroids have generally been 
the most predictable effective medication in human 
PG when delivered in adequate doses. The overall 
prognosis of human PG is good in those patients who 
readily respond to treatment (Ruocco et al., 2009). In 
this case, monotherapy with prednisolone was elected 
because the dog could readily be controlled with pred-
nisolone 1 mg/kg given twice daily. Within a week, 
the cutaneous pain had markedly decreased (in human 
the literature described as the first sign of remission) 
(Bardagi et al., 2007), and nasal stridor had ceased. 
At five weeks of treatment, all the skin lesions had 
completely resolved. Prednisolone dosage and the fre-
quency of administration were reduced and stopped 
after six weeks. There was permanent scarring and no 
recurrences.
In summary, PG in dogs is a rare and markedly 
painful, ulcerative skin condition, which may have 
nasal mucosa involvement. Glucocorticoids alone can 
be an effective treatment option in some cases.
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